FDA-led study highlights tradeoffs in drug promotion on social media

Regulatory NewsRegulatory NewsAdvertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProduct Lifecycle